Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A study finds that CD4 cells decline after people with HIV contract hepatitis C.
A review of randomized controlled trials found that the main apparent benefit of such testing occurred among those with virologic failure.
This holds true regardless of how long they’ve had HIV or whether they’re on antiretrovirals.
A lesson that adherence to HIV medication is a reality, even for long-term survivors
Those who begin antiretrovirals with a higher CD4 count and CD4 to CD8 ratio are more likely to experience immune recovery.
Just ask Nicholaus Johnson, a former “junkie” with AIDS who is now a sober college student helping the HIV community.
People who have a low CD4 count, have cirrhosis and take certain hep C drug regimens are less likely to be cured.
Her metamorphosis from gay banker to “trans-species reptilian” began after an HIV diagnosis in 1997.
Researchers will genetically engineer participants’ CD4 cells, disabling the attachment of the virus.
Defective copies of HIV distract the immune system in order to promote overall infection.
The country is urged to offer treatment to everyone who has HIV regardless of CD4 count; most cases are among young men.
Treating HIV early, before CD4s drop significantly, lowers the risk of infection-related cancers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.